Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MiBo Medical Group is a private U.S. ophthalmic medical device company focused on dry eye and meibomian gland dysfunction treatment. The company designs and markets office-based ultrathermotherapeutic devices and related dry eye products for eye care practices. Its lead commercial product, MiBo Thermoflo, delivers controlled external heat and massage therapy to improve meibomian gland function and support tear film stability in patients with evaporative dry eye disease. MiBo positions its offering as a comfortable, repeatable, physician-controlled procedure with no disposables. The company also sells associated dry eye care products through its affiliated dry eye product channel.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MiBo Medical Group.